<DOC>
	<DOCNO>NCT01509391</DOCNO>
	<brief_summary>In study investigator examine safety efficacy Keyhole-limpet-hemocyanin patient chronic hepatitis c infection liver cirrhosis . The investigator hypothesize administration keyhole-limpet-hemocyanin reduces viral load patient infect hepatitis c .</brief_summary>
	<brief_title>Keyhole Limpet Hemocyanin Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Keyhole-limpet hemocyanin</mesh_term>
	<criteria>Chronic Hepatitis C infection previous therapy least one contraindication interferon therapy liver cirrhosis age 1880 woman childbearing age Hypersensitivity keyholelimpet hemocyanin previous treatment hepatitis c autoimmune disorder immunosuppression hepatocellular carcinoma malignancy coinfection hepatitis b HIV pregnancy cardiovascular event last 6 month ( stroke MCI ) uncontrolled diabetes renal insufficiency ( GFR &lt; 50 ml/min ) chronic hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>